Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors

Molecular Cell

Volumn 2, Issue 3, 1998, Pages 283-292

  Pan, Huichin ^a,c   Yin, Chaoying ^a   Dyson, Nicholas J ^b   Harlow, Ed ^b   Yamasaki, Lili ^b,d   Van Dyke, Terry ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; E2F1 PROTEIN, MOUSE; PROTEIN P53; RETINOBLASTOMA BINDING PROTEIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1;

ANIMAL; APOPTOSIS; ARTICLE; BRAIN; BRAIN CIRCULATION; BRAIN TUMOR; CELL DIVISION; CYTOLOGY; GENETICS; HETEROZYGOTE; HOMOZYGOTE; METABOLISM; MOUSE; MOUSE MUTANT; ONCOGENE; PATHOLOGY; PHYSIOLOGY; TRANSACTIVATION; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE; VASCULAR ENDOTHELIUM;

ANIMALS; APOPTOSIS; BRAIN; BRAIN NEOPLASMS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL DIVISION; CEREBROVASCULAR CIRCULATION; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; ENDOTHELIUM, VASCULAR; GENES, P53; GENES, TUMOR SUPPRESSOR; HETEROZYGOTE; HOMOZYGOTE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; ONCOGENES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032160407     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80273-7     Document Type: Article

References (58)

1. Adams, P.D., and Kaelin, W.G., Jr. (1995). Transcriptional control by E2F. Semin. Cancer Biol. 6(2), 99-108.
2. Almasan, A., Yin, Y., Kelley, R.E., Lee, E.Y.H.P., Bradley, A., Li, W., Bertino, J., and Wahl, G.M. (1995). Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc. Natl. Acad. Sci. USA 92(12), 5436-5440.
3. Asano, M., Nevins, J.R., and Wharton, R.P. (1996). Ectopic E2F expression induces S phase and apoptosis in Drosophila imaginal discs. Genes Dev. 10, 1422-1432.
4. Beijersbergen, R.L., Kerkhoven, R.M., Zhu, L., Carlee, L., Voorhoeve, P.M., and Bernards, R. (1994). E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8(22), 2680-2690.
5. Chen, J., Neilson, K., and Van Dyke, T. (1989). Lymphotropic papovavirus early region is specifically regulated in transgenic mice and efficiently induces neoplasia. J. Virol. 63, 2204-2214.
6. Debbas, M., and White, E. (1993). Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7, 546-554.
7. DeGregori, J., Kowalik, T., and Nevin, J.R. (1995). Cellular targets for activation by the E2F1 transcription factor include DNA synthesis and G1/S-regulatory genes. Mol. Cell. Biol. 15, 4215-4224.
8. DeGregori, J., Leone, G., Miron, A., Jakoi, L., and Nevins, J.R. (1997). Distinct roles for E2F proteins in cell growth control including a unique role for the E2F1 protein as a signal for apoptosis. Proc. Natl. Acad. Sci. USA 94, 7245-7250.
9. Du, W., Xie, J-E., and Dyson, N. (1996). Ectopic expression of dE2F and dDP induces cell proliferation and death in the Drosophila eye. EMBO J. 15, 3684-3692.
10. Duronio, R.J., Bonnette, P.C., and O'Farrell, P.H. (1998). Mutations of the Drosophila dDP, dE2F, and cyclin E genes reveal distinct roles for the E2F-DP transcription factor and cyclin E during the G1-S transition. Mol. Cell. Biol. 18, 141-151.
11. Field, S.J., Tsai, F.Y., Kuo, F., Zubiaga, A.M., Kaelin, W.G., Jr., Livingston, D.M., Orkin, S.H., and Greenberg, M.E. (1996). E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85, 549-561.
12. Fromm, L., Shawlot, W., Gunning, K., Butel, J., and Overbeek, P. (1994). The retinoblastoma protein binding region of simian virus 40 large T antigen alters cell cycle regulation in lenses of transgenic mice. Mol. Cell. Biol. 14(10), 6743-6754.
13. Hendzel, M.J., Wei, Y., Mancini, M.A., Van Hooser, A., Ranalli, T., Brinkley, B.R., Bazett-Jones, D.P., and Allis, C.D. (1997). Mitosis-specific phosphorylation of histone H3 initiates primarily within peicentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106, 348-360.
14. Hiebert, S.W., Packham, D.K., Strom, D.K., Haffner, R., Oren, M., Zambetti, G., and Cleveland, J.L. (1995). E2F1:DP1 induced p53 and overrides survival factors to trigger apoptosis. Mol. Cell. Biol. 15, 6864-6874.
15. Hijmans, E.M., Voorhoeve, P.M., Beijersbergen, R.L., Van'T Veer, L.J., and Bernards, R. (1995). E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15(6), 3082-3089.
16. Hinds, P.W., and Weinberg, R.A. (1994). Tumor suppressor genes. Curr. Biol. 4, 135-141.
17. Hiyama, H., Iavarone, A., LaBaer, J., and Reeves, S.A. (1997). Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression. Oncogene 14, 2533-2542.
18. Hiyama, H., Iavarone, A., and Reeves, S.A. (1998). Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Oncogene 16, 1513-1523.
19. Howes, K.A., Ransom, N., Papermaster, D.S., Lasudry, J.G.H., Albert, D.M., and Windle, J.J. (1994). Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev. 8, 1300-1310.
20. Hsieh, J.-K., Fredersdorf, S., Tony, K., Martin, K., and Lu, X. (1997). E2F1-induced apoptosis required DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 11, 1840-1852.
21. Johnson, D.G., Schwarz, J.K., Cress, W.D., and Nevins, J.R. (1993). Expression of transcription factor E2F1 induces quiescent cells to enters phase. Nature 365, 349-352.
22. Johnson, D.G., Cress, W.D., Jakoi, L., and Nevins, J.R. (1994). Oncogenic capacity of the E2F1 gene. Proc. Natl. Acad. Sci. USA 91, 12823-12827.
23. Kowalik, T.F., DeGregori, J., Schwarz, J.K., and Nevins, J.R. (1995). E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 69(4), 2491-2500.
24. Kowalik, T.F., DeGregori, J., Leone, G., Jakoi, L., and Nevins, J.R. (1998). E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. Cell Growth Differ. 9, 113-118.
25. Lee, E., Hu, N., Yuan, S., Cox, L., Bradley, A., Lee, W., and Herrup, K. (1994). Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev. 8, 2008-2021.
26. Lees, J.A., Satio, M., Vidal, M., Valentine, M., Look, T., Harlow, E., Dyson, N., and Helin, K. (1993). The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13, 7813-7825.
27. Lowe, S., Jacks, T., Housman, D., and Ruley, H. (1994). Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc. Natl. Acad. Sci. USA 91, 2026-2030.
28. Lukas, J., Petersen, B.O., Holm, K., Bartek, J., and Helin, K. (1996). Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol. Cell. Biol. 16, 1047-1057.
29. Lutzker, S.G., and Levine, A.J. (1996). A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nat. Med. 2, 804-810.
30. Macleod, K.F., Hu, Y., and Jacks, T. (1996). Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J. 15(22), 6178-6188.
31. Marshall, C.J. (1991). Tumor suppressor genes. Cell 64, 313-326.
32. Miyashita, T., and Reed, J.C. (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299.
33. Morgenbesser, S., Williams, B., Jacks, T., and DePinho, R. (1994). p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371, 72-74.
34. Pan, H., and Griep, A.E. (1994). Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev. 8, 1285-1299.
35. Pan, H., and Griep, A.E. (1995). Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes Dev. 9, 2157-2169.
36. Pan, H., Yin, C., and Van Dyke, T. (1997). Apoptosis and cancer mechanisms. Cancer Surv. 29, 305-327.
37. Philips, A.C., Bates, S., Ryan, K.M., Helin, K., and Vousden, K.H. (1997). Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 11, 1853-1863.
38. Qin, X.Q., Livingston, D.M., Kaelin, W.G., and Adams, P.D. (1994). Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediatied apoptosis. Proc. Natl. Acad. Sci. USA 91, 10918-10922.
39. Saenz-Robles, M.T., Symonds, H., Chen, J., and Van Dyke, T. (1994). Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen. Mol. Cell. Biol. 14 (4), 2686-2698.
40. Sardet, C., Vidal, M., Cobrinik, D., Geng, Y., Onufryk, C., Chen, A., and Weinberg, R.A. (1995). E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA 92(6), 2403-2407.
41. Sellers, W., Rodgers, J., and Kaelin, W. (1996). A potent transrepression domain in the retinablastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA 92, 11544-11548.
42. Shan, B., and Lee, W. (1994). Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14, 8166-8173.
43. Shan, B., Durfee, T., and Lee, W.H. (1996). Disruption of RB/EBF-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc. Natl. Acad. Sci. USA 93, 679-684.
44. Sherr, C. (1994). The ins and outs of RB: coupling gene expression to the cell cycle clock. Trends. Cell Biol. 4, 15-18.
45. Sherr, C.J. (1996). Cancer cell cycles. Science 274, 1672-1677.
46. Slansky, J.E., and Farnham, P.J. (1996). Introduction to the E2F family: protein structure and gene regulation. Curr. Top. Microbiol. Immunol. 208, 1-30.
47. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., and Van Dyke, T. (1994). p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78, 703-711.
48. Tsai, K.Y., Hu, Y., Macleod, K.F., Crowley, D., Yamasaki, L., and Jacks, T. (1998). Mutation of E2F1 suppresses apoptosis and inappropriate S-phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell 2, 293-304.
49. Weinberg, R.A. (1991). Tumor suppressor genes. Science 254, 1138-1146.
50. Weinberg, R.A. (1995). The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
51. Weintraub, S.J., Chow, K.N., Luo, R.X., Zhang, S.H., He, S., and Dean, D.C. (1995). Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375, 812-815.
52. Wu, H., Wade, M., Krall, L., Grisham, J., Xiong, Y., and Van Dyke, T. (1996).Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocytecell-cycle progression, postnatal liver development, and regeneration. Genes Dev. 10, 245-260.
53. Wu, X., and Levine, A.J. (1994). p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91, 3602-3606.
54. Xu, G., Livingston, D.M., and Krek, W. (1995). Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl. Acad. Sci. USA 92(5), 1357-1361.
55. Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E., and Dyson, N.J. (1996). Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85, 537-548.
56. Yamasaki, L., Bronson, R., Williams, B.O., Dyson, N.J., Harlow, E., and Jacks, T. (1998). Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice. Nat. Genet. 18, 360-362.
57. Yin, C., Knuson, C.M., Korsmyers, J.S, and Van Dyke, T. (1997). Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385, 637-640.
58. Zachsenhaus, E., Jiang, Z., Chung, D., Marth, J.D., and Philips, R.A. (1996). pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 10, 3051-3064.